REVOLDAY-400
MRP: 1,475
Packaging: 400mg
Pack Type: injection
Composition:
Teicoplanin 400mg
Indication:
Septicaemia, Bacteremia, Osteomyelitis, Septic Arthritis.
Description:
Teicoplanin 400 mg Injection is a glycopeptide antibiotic used to treat serious infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other resistant strains. It works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death.
It is commonly used for infections such as bacteremia, endocarditis, skin and soft tissue infections, bone and joint infections, and lower respiratory tract infections. Teicoplanin offers the advantage of a longer half-life, allowing for once-daily dosing and outpatient therapy options.
Tags:
- Effective against MRSA and resistant Gram-positive infections
- Longer half-life allows once-daily dosing
- Suitable for severe infections like endocarditis and osteomyelitis
- Can be used in outpatient parenteral antibiotic therapy (OPAT)
- Well-tolerated with fewer side effects than vancomycin
Usage Information
Dosage
Route: Intravenous (IV) or Intramuscular (IM) injection Typical Dose: Loading dose: 6–12 mg/kg every 12 hours for 3 doses Maintenance dose: 6 mg/kg once daily Dose adjustment required for renal impairment Administered by healthcare professionals
Side Effects
Injection site pain or inflammation Rash or itching Fever or chills Nephrotoxicity (rare) Blood count changes (rare)
Contraindications
Known hypersensitivity to Teicoplanin or glycopeptides Caution in patients with renal impairment Monitor during prolonged therapy for ototoxicity or nephrotoxicity
Availability
Teicoplanin 400 mg injection MRSA antibiotic injection Injectable glycopeptide antibiotic Teicoplanin for serious infections IV antibiotic for Gram-positive bacteria